Combined Treatment with Medications and Psychotherapy

Psychiatry: Third Edition

Volumn 2, Issue , 2008, Pages 2430-2446

  Rutherford, Bret R ^a   Cabaniss, Deborah L ^a,b   Roose, Steven P ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Antidepressant medication; Anxiolytic medication; Combined treatment; Psychotherapy; Study design

Indexed keywords

EID: 84889847557     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470515167.ch113     Document Type: Chapter

References (76)

1. Ablon J and Jones E (1999) Psychotherapy process in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology 67, 64-75.
2. Abramowitz JS (1997) Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology 65, 44-52.
3. Agency for Health Care Policy and Research (1993) Clinical Practice Guideline: Depression in Primary Care, Vol. 2: Treatment of Major Depression. AHCPR Publication 93-0551. US Government Printing Office, Washington, DC, USA.
4. American Psychiatric Association (1993) Practice guideline for major depressive disorder in adults. American Journal of Psychiatry 150: 1-26.
5. nd edition.Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. American Psychiatric Association Press, Arlington, VA, USA.
6. American Psychiatric Association Press (2006b) Practice Guideline for the Treatment of Patients with Panic Disorder.Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. American Psychiatric Association Press, Arlington, VA, USA.
7. Barlow DH, Gorman JM, Shear MK, et al. (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. The Journal of the American Medical Association 283, 2529-2536.
8. Beck AT, Ward CH, Mendelson M, et al. (1961) An inventory of measuring depression. Archives of General Psychiatry 4, 53-63.
9. Beitman BD and Klerman GL (1991) Integrating Pharmacotherapy and Psychotherapy. American Psychiatric Press, Washington, DC, USA.
10. Black DW, Wesner R, Bowers W, et al. (1993) A comparison of fluvoxam-ine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry 50, 44-50.
11. Blackburn IM, Bishop S, and Glen AIM (1981) The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry 139, 181-189.
12. Blackburn IM, Eunson KM, and Bishop S (1986) A two year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy, or a combination of both. Journal of Affective Disorders 10, 67-75.
13. Browne G, Steiner M, Roberts J, et al. (2002) Sertraline, and/or interpersonal therapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. Journal of Affective Disorders 68, 317-330.
14. Burnand Y, Andreoli A, Kolatte E, et al. (2002) Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatric Services 53, 585-590.
15. Casacalenda N, Perry JC, and Looper K (2002) Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions. The American Journal of Psychiatry 159, 1354-1360.
16. Clark DM, Ehlers A, McManus F, et al. (2004) Cognitive therapy versus fluoxetine in generalized social phobia: A randomized, placebo-controlled trial. Journal of Consulting and Clinical Psychology 71, 1058-1067.
17. Clark DM, Salkovskis PM, Hackmann A, et al. (1994) A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry 164, 759-69.
18. Conte HR, Plutchik R, Wild KV, et al. (1986) Combined psychotherapy and pharmacotherapy for depression: A systematic analysis of the evidence. Archives of General Psychiatry 43, 471-479.
19. Cooper A (1990) Will neurobiology influence psychoanalysis? The American Journal of Psychiatry 142, 1395-1402.
20. Davidson JRT, Foa EB, Huppert JD, et al. (2004) Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry 61, 1005-1013.
21. Derogatis LR (1992) The Symptom Checklist-90-revised. NCS Assessments, Minneapolis, MN, USA.
22. DeRubeis RJ, Gelfand LA, Tang TZ, et al. (1999) Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons. American Journal of Psychiatry 156, 1007-1013.
23. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. (2005) Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62, 409-416.
24. Dimidjian S, Hollon SD, Dobson KS, et al. (2006) Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658-670.
25. Elkin I, Parloff MB, Hadley SW, et al. (1985) NIMH Treatment of Depression Collaborative Research Program: Background and research plan. Archives of General Psychiatry 42, 305-316.
26. Elkin I, Shea MT, Watkins JT, et al. (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Archives of General Psychiatry 46, 971-982.
27. Endicott J, Spitzer RL, and Fleiss JL (1976) The Global Assessment Scale. Archives of General Psychiatry 33, 766-771.
28. Fava GA (1999) Potential sensitizing effects of antidepressant drugs on depression. CNS Drugs 12, 247-256.
29. Foa EB, Liebowitz MR, Kozak MJ, et al. (2005) Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162, 151-161.
30. Frank E, Kupfer DJ, Perel JM, et al. (1990) Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 47, 1093-1099.
31. Frank E, Novick D, and Kupfer DJ (2005) Antidepressants and psychotherapy: A clinical research review. Dialogues in Clinical Neuroscience 7, 263-272.
32. Frank E, Prien RF, Jarrett RB, et al. (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851-855.
33. Furukawa TA, Watanabe N, and Churchill R (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia. British Journal of Psychiatry 188, 305-312.
34. Goldhamer P (1983) Psychotherapy and pharmacotherapy: The challenge of integration. Canadian Journal of Psychiatry: Revue Canadienne de Psychiatrie 28, 173-177.
35. Haan ED, Hoogduin KAL, Buitelaar JK, et al. (1998) Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 37, 1022-1029.
36. Hamilton M (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50-55.
37. Hamilton M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
38. Hollon SD, DeRubeis RJ, Evans MD, et al. (1992) Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Archives of General Psychiatry 49, 774-781.
39. Hollon SD, Jarrett RB, Nierenberg AA, et al. (2005) Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment? Journal of Clinical Psychiatry 66, 455-468.
40. Jarrett RB, Schaffer M, McIntire D, et al. (1999) Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Archives of General Psychiatry 56, 431-437.
41. Kantor S (1990) When is psychotherapy not enough? The Psychiatric Clinics in North America 13, 241-254.
42. Keller MG, McCullough JP, Klein DN, et al. (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342, 1462-1470.
43. Klein DF (1990) NIMH collaborative research on treatment of depression. Archives of General Psychiatry 47, 682-684.
44. Klein DF (1996) Preventing hung juries about therapy studies. Journal of Consulting and Clinical Psychology 64, 81-87.
45. Klein D (1997) Control groups in pharmacotherapy and psychotherapy evaluations. Treatment 1, 1-10. http://journals.apa.org/treatment/vol1/97_a1.html
46. Klein DF and Ross DC (1993) Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program general effectiveness report. Neuropsychopharmacology 8, 241-251.
47. Klerman GL, DiMascio A, Weissman MM, et al. (1974) Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry 131, 186-191.
48. Klosko JS, Barlow DH, Tassinari R, et al. (1990) A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology 58, 77-84.
49. Kubie LS and Margon S (1945) The therapeutic role of drugs in the process of repression, dissociation and synthesis. Psychosomatic Medicine 147-151.
50. Kupfer DJ, Frank E, Perel JM, et al. (1992) Five-year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry 49, 769-773.
51. Marks IM, Swinson RP, Basoglu M, et al. (1993) Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. British Journal of Psychiatry 162, 776-787.
52. Marmor J (1981) The adjunctive use of drugs in psychotherapy. Journal of Clinical Psychopharmacology 1, 312-315.
53. McGrath PJ, Stewart JW, Fava M, et al. (2006) Tranylcypromine versus ven-lafaxine plus mirtazipine following three failed antidepressant medication trials for depression: A STAR*D report. American Journal of Psychiatry 163, 1531-1541.
54. Murphy G, Simons AD, Wetzel RD, et al. (1984) Cognitive therapy and pharmacotherapy. Archives of General Psychiatry 41, 33-41.
55. Nierenberg A A, Fava M, Trivedi MH, et al. (2006) A Comparison of lithium and T3 augmentation following two failed medication treatments for depression: A STAR*D report. American Journal of Psychiatry 163, 1519-1530.
56. Norman W and Bluestone H (1986) The use of pharmacotherapy in psychoanalytic treatment. Contemporary Psychoanalysis 22, 218-234.
57. Pampalona S, Bollini P, Tibaldi G, et al. (2004) Combined pharmacotherapy and psychological treatment for depression. Archives of General Psychiatry 61, 714-719.
58. Paykel ES (1995) Risks of not achieving remission of symptoms are well established. Psychological Medicine 25, 1171-1180.
59. Paykel ES, Scott J, Teasdale JD, et al. (1999) Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry 56, 829-835.
60. Pediatric OCD Treatment Study (POTS) Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled clinical trial. JAMA: The Journal of the American Medical Association 292(16), 1969-1976.
61. Pinquart M, Duberstein PR, and Lyness JM (2006) Treatments for later-life depressive conditions: A meta-analytic comparison of pharmacotherapy and psychotherapy. American Journal of Psychiatry 163, 1493-1501.
62. Ravindran AV, Anisman H, Merali Z, et al. (1999) Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments. American Journal of Psychiatry 156, 1608-1617.
63. Reynolds CF, Miller MD, Pasternak RE, et al. (1999) Treatment of bereavement-related major depressive episodes in later life: A controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. American Journal of Psychiatry 156, 202-208.
64. Riba M and Balon R (2005) Competency in Combining Pharmacotherapy and Psychotherapy: Integrated and Split Treatment. American Psychiatric Association Press, Washington, DC, USA.
65. Rush AJ, Beck AT, Kovacs M, et al. (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Therapy and Research 1, 17-37.
66. Rush AJ, Trivedi MH, Wisniewski SR, et al. (2006) Buproprion SR, sertraline, or venlafaxine XR after failure of SSRIs for depression. New England Journal of Medicine 354, 1231-1242.
67. Rutherford BR, Sneed JR, and Roose SP (2007) Does Study Design Influence Outcome? The Effects of Placebo Control and Treatment Duration in Antidepressant Trials. (Unpublished data)
68. Scott J, Teasdale JD, Paykel ES, et al. (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry 177, 440-446.
69. Sneed J, Rutherford B, Rindskopf D, et al. (2007) Design makes a difference: A meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. The American Journal of Geriatric Psychiatry, (e-pub. ; doi: 10. 1097/JGP. 0b013e3181256b1d)
70. Thase MR, Friedman ES, Biggs MM, et al. (2007) Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. American Journal of Psychiatry 164, 739-752.
71. Thase ME, Greenhouse JB, Frank E, et al. (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Archives of General Psychiatry 54, 1009-1015.
72. Thompson LW, Coon DW, Gallagher-Thompson D, et al. (2001) Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. American Journal of Geriatric Psychiatry 9, 225-240.
73. Treatment for Adolescents with Depression Study (TADS) Team (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA: The Journal of the American Medical Association 292(7), 807-820.
74. Trivedi MH, Fava M, Wisniewski SR, et al. (2006a) Medication augmentation after the failure of SSRIs for depression.New England Journal of Medicine354, 1243-1252.
75. Trivedi MH, Rush AJ, Wisniewski SR, et al. (2006b) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry 163, 28-40.
76. Van Balkom AJLM, van Oppen P, Vermeulen A, et al. (1994) A metaanalysis on the treatment of obsessive-compulsive disorder: A comparison of anti-depressants, behavior, and cognitive therapy. Clinical Psychology Review 14, 359-381.